Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Health Information Framing, Source Characteristics, and Health Behavior Promotion

8 de novembro de 2026 atualizado por: Jing Guo, Peking University

Research on Health Information Framework, Information Sources and Promotion of Health Behaviors

This study examines how different ways of presenting health information affect health-related understanding, decision-making, and behavior. It includes two connected research components: one focuses on vaccination-related decisions, and the other focuses on mental health and help-seeking. Participants will complete an online questionnaire and will be randomly assigned to different information conditions that vary in message framing, information source, social norms, and presentation format. The study will compare post-exposure decision intentions and behavioral responses across the assigned conditions. No medicines, vaccines, or medical devices will be administered as part of the study.

Visão geral do estudo

Status

Ainda não está recrutando

Condições

Descrição detalhada

Health information can influence how people understand health risks, evaluate available options, and make health-related decisions. This prospective behavioral study will use an online questionnaire and a randomized parallel-group design to evaluate how different characteristics of health information affect health-related decision intention and behavioral responses.

The study consists of two connected components conducted in different participant populations and regions. The first component examines how the source and framing of vaccination-related information influence participants' evaluation, decision intention, trust, and subsequent behavioral choices. The second component examines how differently framed mental health information, source cues, and social norms influence mental health-related decision-making and help-seeking responses.

In each component, eligible participants will provide informed consent and will be randomly assigned through an online survey platform to one of several pre-specified information conditions or a comparison condition. Outcomes will be assessed through self-reported questionnaire measures and behavioral responses recorded by the survey platform, including the decision to view further information or proceed with an available follow-up action.

The study does not administer or evaluate the safety or efficacy of any drug, biological product, vaccine, or medical device. All study procedures will be conducted using a secure online platform in accordance with the approved study protocol and applicable ethical requirements.

Tipo de estudo

Intervencional

Inscrição (Estimado)

102000

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Locais de estudo

    • Beijing Municipality
      • Beijing, Beijing Municipality, China, 101118
        • Beijing Tongzhou Psychiatric Hospital
        • Contato:
    • Hunan
      • Changsha, Hunan, China
        • The Third Xiangya Hospital of Central South University
        • Contato:
          • Xiuhong Yuan, PhD
          • Número de telefone: 86+15308488051
          • E-mail: 18483195@qq.com

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

10 anos e mais velhos (Filho, Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Aged 10 years or older.
  • Component 1: Young adults entering higher education who meet the age and enrollment requirements specified in the approved protocol.
  • Component 2: Adolescents and their primary caregivers who meet the age, grade, recruitment-site, and paired-participation requirements specified in the approved protocol.
  • Able to understand the study information and complete the online questionnaire with any assistance permitted by the approved protocol.
  • Voluntarily participates and provides electronic informed consent. For minors, guardian consent and participant assent are obtained as required.

Exclusion Criteria:

  • Unable to provide informed consent or, where applicable, guardian consent and participant assent.
  • Does not meet the eligibility requirements for either study component.
  • Component 1: Has already completed the relevant full vaccination schedule, where specified as an exclusion criterion in the approved protocol.
  • Questionnaire response is invalid because of severe missingness, an implausible completion time, failed quality-control items, or clear logical inconsistency.
  • Any additional component-specific exclusion criterion specified in the approved protocol.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Pesquisa de serviços de saúde
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Sem intervenção: No-information control (Component 1)
Experimental: AI-sourced gain-framed message (Component 1)

Participants view an AI-sourced message emphasizing the benefits of vaccination.

Experimental: AI-sourced loss-framed message (Component 1)

Participants view an AI-sourced message emphasizing the risks of not being vaccinated.

Experimental: AI-sourced normative message (Component 1)

Participants view an AI-sourced message emphasizing social or public-health approval of vaccination.

Experimental: AI-sourced structured message (Component 1)

Participants view an AI-sourced message explaining vaccination and booking procedures in a structured format.

Experimental: AI-sourced expert-authority message (Component 1)

Participants view an AI-sourced message attributed to professional or expert authority.

Experimental: Official gain-framed message (Component 1)

Participants view an official message emphasizing the benefits of vaccination.

Experimental: Official loss-framed message (Component 1)

Participants view an official message emphasizing the risks of not being vaccinated.

Experimental: Official normative message (Component 1)

Participants view an official message emphasizing social or public-health approval of vaccination.

Experimental: Official structured message (Component 1)

Participants view an official message explaining vaccination and booking procedures in a structured format.

Experimental: Official expert-authority message (Component 1)

Participants view an official message attributed to professional or expert authority.

Experimental: Gain-framed peer message (Component 2)

Participants view a gain-framed message emphasizing the benefits of mental health help-seeking, with peer social cues.

Experimental: Gain-framed expert message (Component 2)

Participants view a gain-framed message emphasizing the benefits of mental health help-seeking, attributed to an expert source.

Experimental: Loss-framed peer message (Component 2)

Participants view a loss-framed message emphasizing the risks of not seeking mental health support, with peer social cues.

Experimental: Loss-framed expert message (Component 2)

Participants view a loss-framed message emphasizing the risks of not seeking mental health support, attributed to an expert source.

Experimental: Social-norm message (Component 2)

Participants view a message presenting help-seeking as a common and socially approved behavior.

Sem intervenção: Blank-reminder control (Component 2)

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
HPV vaccination intention
Prazo: Immediately after exposure to the assigned health information condition (post-exposure questionnaire).

In the Hunan population, assessed immediately after exposure with one 5-point item: "I am willing to receive the HPV vaccine in the future." Responses range from

1 (strongly disagree) to 5 (strongly agree). Higher scores indicate stronger intention to receive the HPV vaccine.

Immediately after exposure to the assigned health information condition (post-exposure questionnaire).
Professional mental health help-seeking intention
Prazo: Immediately after exposure to the assigned health information condition (post-exposure questionnaire).

In Tongzhou students and primary caregivers, assessed using three 7-point items asking how likely the participant would be to seek help from a psychologist, a psychiatrist, and another doctor if experiencing persistent emotional distress or thoughts of self-harm. Scores range from 1 (definitely would not) to 7 (definitely would). The mean of the three items will be calculated; higher scores indicate stronger professional help-seeking intention.

Immediately after exposure to the assigned health information condition (post-exposure questionnaire).
HPV vaccination booking-directed action
Prazo: During the same online session immediately after exposure to the assigned health information condition.

In the Hunan population, a binary behavioral outcome recorded by the online questionnaire platform after exposure. A positive response is defined as either selecting direct booking at the first decision point or agreeing to provide contact information for HPV vaccination booking at the end of the booking pathway. Viewing information without proceeding to booking or providing contact information is not counted as a positive response.

During the same online session immediately after exposure to the assigned health information condition.

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
HPV vaccine trust
Prazo: Immediately after exposure to the assigned health information condition.

In the Hunan population, assessed with five HPV-adapted Vaccine Trust Gauge items covering vaccine safety, protection against serious illness, relative health risk, benefits versus risks, and effectiveness. Responses will be scored in the direction of greater trust using the prespecified VTG scoring and missing response rules. The item mean will be rescaled to 0-100; higher scores indicate greater trust.

Immediately after exposure to the assigned health information condition.
Trust in HPV vaccine information sources
Prazo: Immediately after exposure to the assigned health information condition.

In the Hunan population, assessed with five Vaccine Trust Gauge-adapted items measuring trust in HPV vaccine recommendations from schools or official institutions, doctors or nurses, family or friends, classmates or peers, and social media. Responses will be scored using the same prespecified VTG rules. The item mean will be rescaled to 0-100; higher scores indicate greater trust.

Immediately after exposure to the assigned health information condition.
HPV vaccination readiness (7C-based)
Prazo: Immediately after exposure to the assigned health information condition.

In the Hunan population, assessed using seven HPV-adapted 7C vaccination- readiness items covering calculation, collective responsibility, confidence in the system, confidence in vaccine safety, social conformity, convenience or constraints, and complacency. Items will be reverse scored where required and averaged so that higher scores indicate greater vaccination readiness.

Immediately after exposure to the assigned health information condition.
Perceived susceptibility to HPV infection
Prazo: Immediately after exposure to the assigned health information condition.

In the Hunan population, assessed using the mean of three 5-point Health Belief Model items representing perceived susceptibility to HPV infection. Items will be reverse scored as specified in the analysis plan so that higher scores indicate greater perceived susceptibility.

Immediately after exposure to the assigned health information condition.
Perceived severity of HPV infection
Prazo: Immediately after exposure to the assigned health information condition.

In the Hunan population, assessed using one reverse-scored 5-point Health Belief Model item concerning whether the health effects of HPV infection are not serious. The score will be transformed so that higher scores indicate greater perceived severity.

Immediately after exposure to the assigned health information condition.
Perceived barriers to HPV vaccination
Prazo: Immediately after exposure to the assigned health information condition.

In the Hunan population, assessed using the mean of six 5-point Health Belief Model items concerning perceived drawbacks, cost, insufficient information, uncertain long-term side effects, sexual stigma, and sensitivity of the topic. Higher scores indicate greater perceived barriers to HPV vaccination.

Immediately after exposure to the assigned health information condition.
Cues to action for HPV vaccination
Prazo: Immediately after exposure to the assigned health information condition.

In the Hunan population, assessed using the mean of two 5-point Health Belief Model items concerning exposure to media reports promoting HPV vaccination and the influence of a doctor's recommendation. Higher scores indicate stronger cues to action.

Immediately after exposure to the assigned health information condition.
Help-seeking efficacy attitudes related to mental health
Prazo: Immediately after exposure to the assigned school-based health message.

In Tongzhou students and primary caregivers, assessed using the Help-Seeking dimension of the Universal Mental Health Literacy Scale for Adolescents (UMHL-A). Five applicable items are used in students and four in caregivers. Items are scored on a 5-point scale, averaged, and rescaled to 0-100. Higher scores indicate more favorable help-seeking attitudes.

Immediately after exposure to the assigned school-based health message.
Stigma-related attitudes toward mental health
Prazo: Immediately after exposure to the assigned school-based health message.

In Tongzhou students and primary caregivers, assessed using the three-item Stigma dimension of the Universal Mental Health Literacy Scale for Adolescents (UMHL-A). Items are scored on a 5-point scale, averaged, and rescaled to 0-100 in the direction of less stigmatizing and more favorable attitudes.

Immediately after exposure to the assigned school-based health message.
Intention to use generative AI for HPV vaccination information
Prazo: Immediately after exposure to the assigned health information condition.

In the Hunan population, assessed using two post-exposure 5-point items asking whether the participant is willing to use an AI chatbot to obtain further HPV vaccination information and whether generative AI would be used as one source of HPV vaccination information. Both items will be coded in the direction of greater intention and averaged.

Immediately after exposure to the assigned health information condition.
Benevolence dimension of trust in generative AI for health information
Prazo: Immediately after exposure to the assigned health information condition.

In Hunan and Tongzhou participants, assessed using the three-item Benevolence dimension of the Human-Generative AI Trust Scale, adapted to HPV vaccination or mental health information. The items assess whether generative AI acts in the participant's best interest, is willing to understand the participant's needs and preferences, and will help to the best of its ability. Items use a 5-point response scale and are averaged; higher scores indicate greater benevolence-based trust.

Immediately after exposure to the assigned health information condition.
Competence dimension of trust in generative AI for health information
Prazo: Immediately after exposure to the assigned health information condition.

In Hunan and Tongzhou participants, assessed using the three-item Competence dimension of the Human-Generative AI Trust Scale. The items assess whether generative AI can effectively support the participant in understanding health information, performs well in providing health information support, and has the expected functions for that role. Items use a 5-point response scale and are averaged; higher scores indicate greater competence-based trust.

Immediately after exposure to the assigned health information condition.
Reciprocity or dependency dimension of trust in generative AI for health information
Prazo: Immediately after exposure to the assigned health information condition.

In Hunan and Tongzhou participants, assessed using the three-item Reciprocity or Dependency dimension of the Human-Generative AI Trust Scale. The items assess whether participants believe they can rely on generative AI, whether it can continue to support health decisions, and whether they refer to health information provided by generative AI. Items use a 5-point response scale and are averaged; higher scores indicate greater reciprocity-based trust.

Immediately after exposure to the assigned health information condition.
Psychological resilience
Prazo: Immediately after exposure to the assigned school-based health message.

In Tongzhou students and primary caregivers, assessed immediately after exposure using the 10-item Connor-Davidson Resilience Scale (CD-RISC-10). Each item is scored from 0 (not true at all) to 4 (true nearly all the time). The 10 item scores are summed to a total score ranging from 0 to 40; higher scores indicate greater psychological resilience. If the online platform stores responses as 1-5, scores will be recoded to 0-4 before summation.

Immediately after exposure to the assigned school-based health message.

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

28 de novembro de 2026

Conclusão Primária (Estimado)

28 de novembro de 2029

Conclusão do estudo (Estimado)

28 de novembro de 2029

Datas de inscrição no estudo

Enviado pela primeira vez

27 de outubro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

8 de novembro de 2026

Primeira postagem (Real)

10 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

10 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

8 de novembro de 2026

Última verificação

1 de outubro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • E 26964
  • E 26964 (Outro identificador: Ethics Committee of the Third Xiangya Hospital of Central South University)

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .